The focus of this laboratory has been the MHC class I molecule, classically considered a molecular heterodimer consisting of a 46 kd polymorphic heavy chain, exemplified by the murine H-2K, D, and L molecules (analogous to the human HLA-A, -B, and -C molecules), that is non-covalently assembled with the 12 kd monomorphic light chain, Beta2-microglobulin. Our objectives in these studies have been to examine a number of specific aspects of the biosynthesis, structure, and function of the class I molecule, including: 1) the measurement of the biochemical parameters that govern the binding of the MHC class I molecule to antigenic peptide; 2) the influence of Beta2-microglobulin and other serum factors on functional and biochemical binding of MHC class I molecules to antigenic peptides; 3) the expression, folding, assembly, structure, and stability of class I molecules produced in: a) an in vitro RNA-dependent translation system and b) an insect virus/moth ovary cell expression system; 4) the expression folding, assembly, structure, and stability of domain and sub-domain fragments of class I molecules generated by recombinant DNA methods, and expressed in tissue culture cells; 5) the function of soluble MHC class I molecules in a transgenic mouse model system; and 6) the production of single chain MHC class I molecules to examine the role of the heavy chain/Beta2-microglobulin interaction in the function and stability of these molecules and as the basis for high level production in prokaryotic systems.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000394-08
Application #
3803173
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1991
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Morozov, Giora I; Zhao, Huaying; Mage, Michael G et al. (2016) Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing. Proc Natl Acad Sci U S A 113:E1006-15
Margulies, David H (2009) Home schooling of NK cells. Immunity 30:313-5
Hu, Jin-Shan; Plaksin, Daniel; Margulies, David H (2005) Backbone and side chain resonance assignmentsof a TRAV14-3 mouse T cell receptor domain. J Biomol NMR 31:271-2
Margulies, David H (2005) Monoclonal antibodies: producing magic bullets by somatic cell hybridization. J Immunol 174:2451-2
Candon, Sophie; McHugh, Rebecca S; Foucras, Gilles et al. (2004) Spontaneous organ-specific Th2-mediated autoimmunity in TCR transgenic mice. J Immunol 172:2917-24
Kuribayashi, Hideki; Wakabayashi, Ayako; Shimizu, Masumi et al. (2004) Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice. Biochem Biophys Res Commun 316:356-63
Dam, Julie; Guan, Rongjin; Natarajan, Kannan et al. (2003) Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b). Nat Immunol 4:1213-22
Lukashev, Dmitriy E; Caldwell, Charles C; Chen, Pearl et al. (2003) A serine/threonine phosphorylation site in the ectodomain of a T cell receptor beta chain is required for activation by superantigen. J Recept Signal Transduct Res 23:33-52
Margulies, David H (2003) CD28, costimulator or agonist receptor? J Exp Med 197:949-53
Margulies, David H (2003) Molecular interactions: stiff or floppy (or somewhere in between?). Immunity 19:772-4

Showing the most recent 10 out of 34 publications